Literature DB >> 26572459

Association of Lactobacillus crispatus with fructo-oligosaccharides and ascorbic acid in hydroxypropyl methylcellulose vaginal insert.

Beatrice Vitali1, Angela Abruzzo2, Carola Parolin3, Rogers Alberto Ñahui Palomino4, Francesco Dalena5, Federica Bigucci6, Teresa Cerchiara7, Barbara Luppi8.   

Abstract

The aim of this work was to develop a synbiotic vaginal insert containing the probiotic strain Lactobacillus crispatus BC5, the prebiotic substrate fructo-oligosaccharide and the antioxidant agent ascorbic acid, for the prophylaxis and therapy of vaginal infections. Mucoadhesive in situ gelling vaginal inserts based on hydroxypropyl methylcellulose were prepared by freeze-drying, stored at +2-8 °C for 90 days and characterized in terms of technological and functional properties. Complete survival of L. crispatus BC5 was found immediately after insert preparation (96.08%) as well as after 90 days of storage (95.82%) in the vaginal inserts containing fructo-oligosaccharide, ascorbic acid and skimmed milk. Synbiotic inserts showed improved mucoadhesion ability (from three- to five-fold) with respect to a standard formulation based on hydroxypropyl methylcellulose alone. Moreover, inserts allowed to modulate lactobacilli release in virtue of the different amounts of fructo-oligosaccharide. Finally, antimicrobial activity was exerted by L. crispatus BC5 released from the vaginal formulation.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ascorbic acid; Fructo-oligosaccharide; In situ gelling inserts; Lactobacillus crispatus; Mucoadhesion; Vaginal release

Mesh:

Substances:

Year:  2015        PMID: 26572459     DOI: 10.1016/j.carbpol.2015.10.035

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  12 in total

1.  Effects of oligosaccharides on the growth and stress tolerance of Lactobacillus plantarum ZLP001 in vitro, and the potential synbiotic effects of L. plantarum ZLP001 and fructo-oligosaccharide in post-weaning piglets1.

Authors:  Jing Wang; Sixin Wang; Hui Liu; Dongyan Zhang; Yamin Wang; Haifeng Ji
Journal:  J Anim Sci       Date:  2019-11-04       Impact factor: 3.159

2.  Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study.

Authors:  Claudio Foschi; Melissa Salvo; Roberto Cevenini; Carola Parolin; Beatrice Vitali; Antonella Marangoni
Journal:  Front Cell Infect Microbiol       Date:  2017-12-06       Impact factor: 5.293

3.  Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.

Authors:  Priscilla Romina De Gregorio; Carola Parolin; Angela Abruzzo; Barbara Luppi; Michele Protti; Laura Mercolini; Jessica Alejandra Silva; Barbara Giordani; Antonella Marangoni; María Elena Fátima Nader-Macías; Beatrice Vitali
Journal:  Microb Cell Fact       Date:  2020-06-18       Impact factor: 5.328

4.  Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections.

Authors:  Francesca Patrignani; Lorenzo Siroli; Carola Parolin; Diana I Serrazanetti; Beatrice Vitali; Rosalba Lanciotti
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

5.  zzm321990 Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm.

Authors:  Angela Abruzzo; Barbara Giordani; Carola Parolin; Priscilla R De Gregorio; Claudio Foschi; Teresa Cerchiara; Federica Bigucci; Beatrice Vitali; Barbara Luppi
Journal:  Antibiotics (Basel)       Date:  2021-01-01

6.  Anti-Candida Activity of Hyaluronic Acid Combined with Lactobacillus crispatus Lyophilised Supernatant: A New Antifungal Strategy.

Authors:  Carola Parolin; Angela Abruzzo; Barbara Giordani; Josidel C Oliver; Antonella Marangoni; Barbara Luppi; Beatrice Vitali
Journal:  Antibiotics (Basel)       Date:  2021-05-25

7.  Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis.

Authors:  Carola Parolin; Claudio Foschi; Luca Laghi; Chenglin Zhu; Nicoletta Banzola; Valeria Gaspari; Antonietta D'Antuono; Barbara Giordani; Marco Severgnini; Clarissa Consolandi; Melissa Salvo; Roberto Cevenini; Beatrice Vitali; Antonella Marangoni
Journal:  Front Microbiol       Date:  2018-03-28       Impact factor: 5.640

8.  Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells.

Authors:  Carola Parolin; Giulia Frisco; Claudio Foschi; Barbara Giordani; Melissa Salvo; Beatrice Vitali; Antonella Marangoni; Natalia Calonghi
Journal:  Front Microbiol       Date:  2018-11-06       Impact factor: 5.640

Review 9.  The Cervicovaginal Mucus Barrier.

Authors:  Guillaume Lacroix; Valérie Gouyer; Frédéric Gottrand; Jean-Luc Desseyn
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

Review 10.  Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes.

Authors:  Barbara Vigani; Silvia Rossi; Giuseppina Sandri; Maria Cristina Bonferoni; Carla M Caramella; Franca Ferrari
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.